Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.

Breast cancer research and treatment - 1 Sept 2018

Liede Alexander, Cai Mona, Crouter Tamara Fidler, Niepel Daniela, Callaghan Fiona, Evans D Gareth

Abstract excerpt

PURPOSE: In 2013, Angelina Jolie disclosed in the New York Times (NYT) that she had undergone risk-reducing bilateral mastectomy (RRBM) after learning that she was a BRCA1 mutation carrier. We examined the rates of BRCA testing and RRBM from 1997 to 2016, and quantified trends before and after the Jolie op-ed. METHODS: This observational study of insurance claims data representative of the commercially-insured US...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Testing

Share to Incidence

Share to Prophylactic Mastectomy

Share to Public Health Surveillance

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 29808287
DOI: 10.1007/s10549-018-4824-9
PMCID: PMC6096880

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.PMID 29808287Read ↗

Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial.Semantic proximity Read ↗

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.Semantic proximity Read ↗

Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United Kingdom.Semantic proximity Read ↗

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.Semantic proximity Read ↗

The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.Semantic proximity Read ↗

Bilateral risk reducing mastectomy uptake trends in healthy BRCA1/2 mutation carriers of an European City, the brachoice study.Semantic proximity Read ↗

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.Semantic proximity Read ↗

Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.Semantic proximity Read ↗

Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.Semantic proximity Read ↗

The Angelina effect: immediate reach, grasp, and impact of going public.Semantic proximity Read ↗

Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.Semantic proximity Read ↗

Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.